NCT06536231 Hemodynamic Variations During Remote Ischemic Conditioning in Critical Ill Patients
| NCT ID | NCT06536231 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Lithuanian University of Health Sciences |
| Condition | Critical Illness |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2024-01-01 |
| Primary Completion | 2024-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2024-01-01 with a primary completion date of 2024-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The main objectives of this study are to evaluate the changes in hemodynamics occurring during the remote ischemic conditioning (RIC) procedure and to compare the hemodynamic responses elicited by passive leg raising before and after the RIC intervention.
Eligibility Criteria
Inclusion Criteria: * aged over 18 years, * admitted to the intensive care unit, * monitored with a transpulmonary thermodilution device with calibrated pulse contour analysis (Pulsion Medical Systems, Munich, Germany), * decision by the physician in charge to perform passive leg raising. Exclusion Criteria: * pregnancy, * advanced malignancy, * peripheral artery disease affecting both arms, * head trauma, * deep vein thrombosis in the lower limbs, * intra-abdominal hypertension, defined as an intra-abdominal pressure greater than 12 mmHg.
Contact & Investigator
Andrius Pranskunas, PhD, prof.
PRINCIPAL INVESTIGATOR
Lithuanian University of Health Sciences
Frequently Asked Questions
Who can join the NCT06536231 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Critical Illness. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06536231 currently recruiting?
Yes, NCT06536231 is actively recruiting participants. Contact the research team at andrius.pranskunas@lsmu.lt for enrollment information.
Where is the NCT06536231 trial being conducted?
This trial is being conducted at Kaunas, Lithuania.
Who is sponsoring the NCT06536231 clinical trial?
NCT06536231 is sponsored by Lithuanian University of Health Sciences. The principal investigator is Andrius Pranskunas, PhD, prof. at Lithuanian University of Health Sciences. The trial plans to enroll 50 participants.